XML 135 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheet (Unaudited) (USD $)
In Millions, unless otherwise specified
Jun. 30, 2013
Dec. 31, 2012
Assets    
Cash and due from banks $ 6,618 $ 8,252
Investment securities    
Held-to-maturity (fair value $34,514 and $34,952, respectively; including $1,019 and $1,482 at fair value pledged as collateral, respectively) (a) 34,668 [1] 34,389 [1]
Available-for-sale ($1,152 and $2,042 pledged as collateral, respectively) (a) 40,307 [1] 40,139 [1]
Loans held for sale (including $4,753 and $7,957 of mortgage loans carried at fair value, respectively) 4,766 7,976
Loans    
Commercial 68,185 66,223
Commercial real estate 38,298 36,953
Residential mortgages 47,753 44,018
Credit Card 16,649 17,115
Other retail 47,105 47,712
Total Loans 217,990 212,021
Covered loans 9,985 11,308
Total loans 227,975 223,329
Less allowance for loan losses (4,312) (4,424)
Net loans 223,663 218,905
Premises and equipment 2,622 2,670
Goodwill 9,156 9,143
Other intangible assets 3,287 2,706
Other assets (including $81 and $47 of trading securities at fair value pledged as collateral, respectively) (a) 28,328 [1] 29,675 [1]
Total assets 353,415 353,855
Deposits    
Noninterest-bearing 70,632 74,172
Interest-bearing 147,693 145,972
Time deposits greater than $100,000 33,243 29,039
Total deposits 251,568 249,183
Short-term borrowings 26,179 26,302
Long-term debt 19,724 25,516
Other liabilities 14,894 12,587
Total liabilities 312,365 313,588
Shareholders' equity    
Preferred stock 4,756 4,769
Common stock, par value $0.01 a share-authorized: 4,000,000,000 shares; issued: 6/30/13 and 12/31/12 -2,125,725,742 shares 21 21
Capital surplus 8,167 8,201
Retained earnings 36,707 34,720
Less cost of common stock in treasury: 6/30/13-281,665,410 shares; 12/31/12 -256,294,227 shares (8,680) (7,790)
Accumulated other comprehensive income (loss) (1,288) (923)
Total U.S. Bancorp shareholders' equity 39,683 38,998
Noncontrolling interests 1,367 1,269
Total equity 41,050 40,267
Total liabilities and equity $ 353,415 $ 353,855
[1] Includes only collateral pledged by the Company where counterparties have the right to sell or pledge the collateral.